
09/13/2025
It was an honor to meet with Secretary Azar and exchange perspectives on the evolving role of pharmaceutical distribution in American healthcare. His unique vantage point - spanning both government leadership at HHS and private-sector experience in biopharma - underscores how critical collaboration between policymakers, distributors, and innovators will be to strengthening access, trust, and transparency in the supply chain.
At Pharmsource, we believe the future of healthcare distribution lies not only in operational excellence but also in harnessing new data and predictive capabilities to ensure patients receive medicines safely, efficiently, and equitably. Conversations like this remind us of the responsibility and opportunity we share as stewards of the business of medicines.
Thank you, HDA - Healthcare Distribution Alliance, for convening this caliber of dialogue and leadership.
Pictured here ( L - R ) :
Pharmsource leadership - Jeff Herman (CEO).
Tom Mullen (Chief Strategy Officer)
The Hon. Alex M. Azar II, 24th U.S. Secretary of Health and Human Services (2018–2021) and former President of Lilly USA.